nicotine has been researched along with galantamine in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (8.89) | 18.7374 |
| 1990's | 1 (2.22) | 18.2507 |
| 2000's | 19 (42.22) | 29.6817 |
| 2010's | 17 (37.78) | 24.3611 |
| 2020's | 4 (8.89) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Adam, BL; Gao, J; Terry, AV | 1 |
| Curtis, MA; Lin, SX; Sperry, J | 1 |
| Gladysheva, NI; Khromova, ON; Prozorovskiĭ, VB | 1 |
| Savateev, NV; Sofronov, GA | 1 |
| Erkova, AI; Savateev, NV; Sherstobitov, OE; Sofronov, GA | 1 |
| Albuquerque, EX; Alkondon, M; Lindstrom, J; Maelicke, A; Peng, X; Pereira, EF; Reinhardt, S; Whiting, P | 1 |
| Albuquerque, EX; Alkondon, M; Aracava, Y; Eisenberg, HM; Maelicke, A; Pereira, EF; Santos, MD | 1 |
| MASHKOVSKII, MD; ROSHCHINA, LF | 1 |
| Dajas-Bailador, FA; Heimala, K; Wonnacott, S | 1 |
| Alés, E; Arias, E; Cano-Abad, MF; Gabilan, NH; García, AG; López, MG; Villarroya, M | 1 |
| Fu, Y; Sharp, BM; Yatsula, M | 1 |
| Ehrhart, J; Fernandez, F; Giunta, B; Shytle, D; Sun, N; Tan, J; Townsend, K; Vendrame, M | 1 |
| Caricati-Neto, A; D'angelo, LC; Garcia, AG; Hyppolito Jurkiewicz, N; Jurkiewicz, A; Reuter, H | 1 |
| Bermudez, I; Groot-Kormelink, PJ; Smulders, CJ; van Kleef, RG; Vijverberg, HP; Zwart, R | 1 |
| Akaike, A; Kanki, R; Kawamata, J; Kihara, T; Nakamizo, T; Sawada, H; Shimohama, S; Yamashita, H | 1 |
| Barik, J; Dajas-Bailador, F; Wonnacott, S | 1 |
| Arias, E; Gallego-Sandín, S; García, AG; López, MG; Villarroya, M | 1 |
| Hedberg, MM; Nordberg, A; Svedberg, MM; Unger, C; Yu, WF | 1 |
| Batra, A; Croissant, B; Diehl, A; Mann, K; Nakovics, H; Smolka, MN | 1 |
| Almkvist, O; Blomquist, G; Darreh-Shori, T; Grut, M; Kadir, A; Långström, B; Nordberg, A; Ringheim, A; Strandberg, B; Wall, A | 1 |
| Kuryatov, A; Lindstrom, J; Onksen, J | 1 |
| Kishimoto, K; Kitamura, Y; Minamino, H; Shibaike, T; Shimohama, S; Takata, K; Takeuchi, H; Taniguchi, T; Tsushima, J; Yanagida, T; Yasui, H | 1 |
| Shimohama, S | 1 |
| Brundage, CM; Nelson, CA; Taylor, BE | 1 |
| Atcha, Z; Aw, CC; Browne, ER; Goh, CW; Lim, JS; Neo, AH; Pemberton, DJ; Rourke, C | 1 |
| Ago, Y; Fukada, A; Kobayashi, H; Koda, K; Matsuda, T; Nishimura, M; Takuma, K; Yano, K | 1 |
| Auber, A; Chiamulera, C; Giarola, A | 1 |
| Gould, TJ; Wilkinson, DS | 1 |
| Blendy, JA; Hayes, MR; Hopkins, TJ; Rupprecht, LE; Schmidt, HD | 1 |
| Herman, AI; Li, Y; Sofuoglu, M; Waters, AJ | 1 |
| Bloem, B; Mansvelder, HD; Poorthuis, RB; Verhoog, MB | 1 |
| Liu, X | 1 |
| Iketani, M; Kakinuma, Y; Mano, A; Oikawa, S | 1 |
| Ashare, RL; Bowers, ME; Hayes, MR; Kimmey, BA; Rupprecht, LE; Schmidt, HD | 1 |
| Alvarez-Jimenez, R; Cohen, AF; de Kam, M; Groeneveld, GJ; Hart, EP; Prins, S; van Gerven, JMA | 1 |
| Groeneveld, GJ; Hart, EP; Linkenkaer-Hansen, K; Mansvelder, HD; Poil, SS; Prins, S; Simpraga, S | 1 |
| Albuquerque, EX; Chiappelli, JJ; Fawcett, WP; Hahn, B; Olmstead, CK; Pereira, EFR; Shrieves, ME; Yuille, MB | 1 |
| Hiramatsu, M; Ito, A; Kato, S; Mamiya, T; Nabeshima, T; Takeuchi, S; Tanase, S | 1 |
| Elmer, GI; Hahn, B; Lane, M; Pereira, EFR; Reneski, CH | 1 |
2 review(s) available for nicotine and galantamine
| Article | Year |
|---|---|
Pyridine alkaloids with activity in the central nervous system.
Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic | 2020 |
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Drug Synergism; Galantamine; Glutamic Acid; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinson Disease, Secondary; Phosphatidylinositol 3-Kinases; Rats; Receptors, Nicotinic; Rotenone; Signal Transduction; Spinal Cord | 2009 |
5 trial(s) available for nicotine and galantamine
| Article | Year |
|---|---|
Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial.
Topics: Administration, Cutaneous; Adult; Alcoholism; Cholinesterase Inhibitors; Cotinine; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Sex Factors; Skin Diseases; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2006 |
PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Brain; Cholinesterase Inhibitors; Double-Blind Method; Enzyme Activation; Female; Galantamine; Humans; Male; Nicotine; Placebo Effect; Positron-Emission Tomography; Protein Binding; Tissue Distribution; Treatment Outcome | 2008 |
Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
Topics: Behavior, Addictive; Blood Pressure; Cholinesterase Inhibitors; Cognition; Connecticut; Cross-Over Studies; Double-Blind Method; Female; Galantamine; Heart Rate; Humans; Infusions, Intravenous; Logistic Models; Male; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Pilot Projects; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Surveys and Questionnaires; Task Performance and Analysis; Time Factors; Tobacco Use Disorder | 2012 |
Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.
Topics: Adolescent; Adult; Cognition; Cross-Over Studies; Double-Blind Method; Drug Interactions; Electroencephalography; Galantamine; Healthy Volunteers; Humans; Male; Mecamylamine; Middle Aged; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Reaction Time; Young Adult | 2018 |
An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds.
Topics: Adolescent; Adult; Brain Waves; Cholinesterase Inhibitors; Cognition; Drug Evaluation; Galantamine; Humans; Machine Learning; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents | 2018 |
38 other study(ies) available for nicotine and galantamine
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Cotinine; Humans; Neurons; Neuroprotective Agents; Nicotine; Peptide Fragments; Rats; Receptors, N-Methyl-D-Aspartate | 2014 |
[Reactivity of isolated rat intestine to choline potentiating compounds].
Topics: Acetylcholine; Ambenonium Chloride; Animals; Cholinesterase Inhibitors; Depression, Chemical; Galantamine; Ileum; In Vitro Techniques; Male; Miotics; Muscle Contraction; Muscle, Smooth; Neostigmine; Nicotine; Nicotinic Acids; Organophosphonates; Parasympathomimetics; Phosphates; Physostigmine; Rats; Stimulation, Chemical | 1971 |
[Effect of anticholinerase substances on the choline reception in the superior cervical sympathetic ganglion of the cat].
Topics: Acetylcholine; Animals; Cats; Chlorides; Cholinesterase Inhibitors; Depression, Chemical; Drug Synergism; Enzyme Repression; Galantamine; Ganglia, Autonomic; Miotics; Nicotine; Organophosphonates; Parasympathomimetics; Pralidoxime Compounds; Receptors, Drug; Stimulation, Chemical | 1971 |
[Some differences in the effects of anticholinesterase compounds on nicotine and arecoline sensitivity in mice and rabbits].
Topics: Animals; Bradycardia; Central Nervous System; Cholinesterase Inhibitors; Galantamine; Heart; Mice; Nicotine; Parasympathomimetics; Peripheral Nerves; Phosphates; Rabbits; Tremor | 1966 |
Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells.
Topics: Animals; Antibodies, Monoclonal; Bacterial Toxins; Binding Sites; Cells, Cultured; Chickens; Cyanobacteria Toxins; Dexamethasone; Dose-Response Relationship, Drug; Fibroblasts; Galantamine; Kinetics; Marine Toxins; Membrane Potentials; Microcystins; Molecular Probes; Neurons; Nicotine; Physostigmine; Receptors, Nicotinic; Recombinant Proteins; Tropanes | 1994 |
The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system.
Topics: Action Potentials; Allosteric Regulation; Animals; Antibodies, Monoclonal; Central Nervous System; Cholinesterases; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Postsynaptic Potentials; Galantamine; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Humans; In Vitro Techniques; Neurons; Nicotine; Nootropic Agents; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Receptors, Glutamate; Synaptic Transmission; Time Factors | 2002 |
[ON THE EFFECT OF OXYLIDINE ON THE BIOELECTRIC ACTIVITY OF THE BRAIN].
Topics: Amphetamine; Animals; Brain; Cats; Cerebral Cortex; Chloral Hydrate; Cholinesterases; Electroencephalography; Electrophysiology; Galantamine; Ganglionic Blockers; Hypnotics and Sedatives; Mesencephalon; Nicotine; Pharmacology; Quinuclidines; Rabbits; Research; Reticular Formation; Sciatic Nerve | 1963 |
The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
Topics: Allosteric Regulation; Animals; Binding Sites; Calcium Signaling; Cholinesterase Inhibitors; Galantamine; Hippocampus; In Vitro Techniques; Male; Neurons; Neurotransmitter Agents; Nicotine; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptic Transmission; Tritium | 2003 |
Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Apoptosis; Blotting, Western; Bungarotoxins; Calcium; Cattle; Cell Line, Tumor; Cholinesterase Inhibitors; Chromaffin Cells; Drug Interactions; Enzyme Inhibitors; Flow Cytometry; Fura-2; Galantamine; Humans; Immunohistochemistry; Neuroblastoma; Nicotine; Peptide Fragments; Proto-Oncogene Proteins c-bcl-2; Rats; Receptors, Nicotinic; Thapsigargin | 2004 |
Effects of galantamine, a nicotinic allosteric potentiating ligand, on nicotine-induced catecholamine release in hippocampus and nucleus accumbens of rats.
Topics: Allosteric Regulation; Animals; Catecholamines; Drug Interactions; Galantamine; Hippocampus; Male; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Rats; Receptors, Nicotinic | 2004 |
Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120.
Topics: Analysis of Variance; Animals; Animals, Newborn; Blotting, Western; Cells, Cultured; Cerebral Cortex; Cholinesterase Inhibitors; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Galantamine; HIV Envelope Protein gp120; Interferon-gamma; Mice; Microglia; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nicotine; Nicotinic Agonists; Nitric Oxide; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Donepezil; Drug Synergism; Electric Stimulation; Galantamine; In Vitro Techniques; Indans; Male; Muscle Contraction; Muscle, Smooth; Nicotine; Nicotinic Agonists; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Wistar; Receptors, Purinergic; Rivastigmine; Stimulation, Chemical; Synaptic Transmission; Tacrine; Vas Deferens | 2004 |
Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
Topics: Acetylcholine; Alkaloids; Animals; Atropine; Azocines; Binding, Competitive; Cholinergic Agents; Cholinesterase Inhibitors; Dichlorvos; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Membrane Potentials; Models, Biological; Nicotine; Oocytes; Phenylcarbamates; Physostigmine; Plasmids; Quinolizines; Receptors, Nicotinic; Rivastigmine; Scopolamine; Tacrine; Xenopus laevis | 2005 |
Stimulation of nicotinic acetylcholine receptors protects motor neurons.
Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Animals; Bungarotoxins; Cell Death; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Dihydro-beta-Erythroidine; Fetus; Galantamine; Glutamic Acid; Immunohistochemistry; Motor Neurons; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, Nicotinic; Spinal Cord | 2005 |
Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells.
Topics: Binding Sites; Calcium; Cell Line, Tumor; Cell Membrane; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Galantamine; Humans; Neuroblastoma; Nicotine; Nicotinic Agonists; Potassium Chloride; Receptors, Nicotinic; Time Factors | 2005 |
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Topics: Aconitine; Amyloid beta-Peptides; Apoptosis; Benzopyrans; Cell Culture Techniques; Cell Line, Tumor; Cholinesterase Inhibitors; Chromones; Donepezil; Dose-Response Relationship, Drug; Enzyme Inhibitors; Galantamine; Humans; Indans; L-Lactate Dehydrogenase; Morpholines; Neuroblastoma; Neuroprotective Agents; Nicotine; Nitriles; Okadaic Acid; Phenylcarbamates; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-bcl-2; Receptors, Nicotinic; Rivastigmine | 2005 |
Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice.
Topics: Amyloid beta-Peptides; Animals; Binding Sites; Blotting, Western; Cerebral Cortex; Cholinesterase Inhibitors; Excitatory Amino Acid Antagonists; Galantamine; Immunohistochemistry; Memantine; Mice; Mice, Transgenic; Nicotine; Peptide Fragments; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Synaptophysin | 2006 |
Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.
Topics: Acetylcholine; Allosteric Regulation; Antibodies, Monoclonal; Binding Sites; Biotinylation; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Galantamine; Humans; Inhibitory Concentration 50; Kidney; Mecamylamine; Mutation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pyridines; Radioimmunoassay; Receptors, Nicotinic; Transfection; Up-Regulation | 2008 |
Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Functional Laterality; Galantamine; Gene Expression Regulation; Male; Mecamylamine; Methamphetamine; Motor Activity; Neuroprotective Agents; Nicotine; Nicotinic Antagonists; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Nicotinic; RNA, Messenger; Rotarod Performance Test; Tyrosine 3-Monooxygenase | 2008 |
Cholinergic sensitivity of the developing bullfrog (Rana catesbeiana) does not explain vulnerability to chronic nicotine exposure.
Topics: Acetylcholine; Animals; Brain Stem; Galantamine; Hypercapnia; Nicotine; Rana catesbeiana; Respiratory Mechanics; Time Factors | 2010 |
Alternative method of oral dosing for rats.
Topics: Administration, Oral; Animals; Behavior, Animal; Donepezil; Galantamine; Indans; Laboratory Animal Science; Male; Nicotine; Nootropic Agents; Piperidines; Rats; Recognition, Psychology; Stress, Physiological; Sucrose; Syringes; Time Factors | 2010 |
Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation.
Topics: Acetylcholinesterase; Animals; Body Temperature; Cholinesterase Inhibitors; Clozapine; GABA Antagonists; Galantamine; Male; Mice; Microdialysis; Motor Activity; Muscarinic Agonists; Nicotine; Nicotinic Agonists; Oxotremorine; Parasympatholytics; Pirenzepine; Receptors, Muscarinic; Reflex, Startle; Sensory Gating; Social Isolation | 2011 |
Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats.
Topics: Animals; Cholinesterase Inhibitors; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Galantamine; Generalization, Stimulus; Male; Nicotine; Nicotinic Agonists; Physostigmine; Rats; Rats, Sprague-Dawley; Tacrine | 2011 |
The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.
Topics: Animals; Cholinesterase Inhibitors; Conditioning, Classical; Dose-Response Relationship, Drug; Drug Administration Schedule; Fear; Galantamine; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Substance Withdrawal Syndrome | 2011 |
Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.
Topics: Allosteric Regulation; Animals; Cholinesterase Inhibitors; Drug-Seeking Behavior; Extinction, Psychological; Galantamine; Male; Nicotine; Rats; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder | 2012 |
Layer-specific interference with cholinergic signaling in the prefrontal cortex by smoking concentrations of nicotine.
Topics: Acetylcholine; Action Potentials; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Animals, Newborn; Bicuculline; Calcium; Cholinesterase Inhibitors; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA-A Receptor Antagonists; Galantamine; In Vitro Techniques; Mice; Mice, Inbred C57BL; Nerve Net; Neurons; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Prefrontal Cortex; Quinoxalines; Receptors, Nicotinic; Signal Transduction | 2013 |
Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.
Topics: Allosteric Regulation; Animals; Azetidines; Dose-Response Relationship, Drug; Galantamine; Hydrocarbons, Brominated; Indole Alkaloids; Male; Nicotine; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement Schedule; Self Administration; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2013 |
Nicotinic receptor-dependent and -independent effects of galantamine, an acetylcholinesterase inhibitor, on the non-neuronal acetylcholine system in C2C12 cells.
Topics: Acetylcholine; Animals; Cell Line; Cholinesterase Inhibitors; Galantamine; Mice; Nicotine; Receptors, Nicotinic; Vascular Endothelial Growth Factor A | 2015 |
Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers.
Topics: Adolescent; Adult; Animals; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Humans; Indans; Male; Middle Aged; Nicotine; Piperidines; Rats; Smoking Prevention; Young Adult | 2016 |
Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects.
Topics: Adult; Cholinesterase Inhibitors; Cognition; Double-Blind Method; Female; Galantamine; Healthy Volunteers; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Nootropic Agents; Reaction Time; Young Adult | 2020 |
Galantamine improves enhanced impulsivity, impairments of attention and long-term potentiation induced by prenatal nicotine exposure to mice.
Topics: Animals; Attention; Behavior, Animal; Dose-Response Relationship, Drug; Female; Galantamine; Impulsive Behavior; Long-Term Potentiation; Mice; Mice, Inbred C57BL; Motor Activity; Nicotine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Nicotinic | 2020 |
Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine by low-dose galantamine in rats.
Topics: Acetylcholinesterase; Allosteric Regulation; Animals; Cholinesterase Inhibitors; Cognition; Conditioning, Operant; Dose-Response Relationship, Drug; Galantamine; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Reaction Time | 2020 |